Skip to product information
1 of 1

NSJ Bioreagents

SKU:F47209-0.08ML

APC Antibody / Adenomatous polyposis coli

APC Antibody / Adenomatous polyposis coli

Regular price $205.00 USD
Regular price Sale price $205.00 USD
Sale Sold out
Shipping calculated at checkout.
Size

This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product.

Specifications

Family Primary antibody
Formulation In 1X PBS, pH 7.4, with 0.09% sodium azide
Format Antigen affinity purified
Host Animal Rabbit
Clonality Polyclonal (rabbit origin)
Isotype Rabbit Ig
Species Reactivity Mouse
Application WB, ELISA
Application Details Western blot: 1:1000
Application Note Titration of the APC antibody may be required due to differences in protocols and secondary/substrate sensitivity.
Immunogen A portion of amino acids 1148-1176 from the human protein was used as the immunogen for this APC antibody.
Purity Antigen affinity
Storage Aliquot the APC antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Limitation This APC antibody is available for research use only.
Uniprot # P25054
Status Available
PDF Link https://www.nsjbio.com/tds-pdf/apc-antibody-adenomatous-polyposis-coli-f47209
Title APC Antibody / Adenomatous polyposis coli
Description This gene encodes a tumor suppressor protein that acts as an antagonist of the Wnt signaling pathway. It is also involved in other processes including cell migration and adhesion, transcriptional activation, and apoptosis. Defects in this gene cause familial adenomatous polyposis (FAP), an autosomal dominant pre-malignant disease that usually progresses to malignancy. Disease-associated mutations tend to be clustered in a small region designated the mutation cluster region (MCR) and result in a truncated protein product.
View full details